User profiles for MIKA RAITANEN

Mika Raitanen

Kirurgian dosentti
Verified email at netikka.fi
Cited by 1643

Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis

MP Raitanen, R Aine, E Rintala, J Kallio, P Rajala… - European urology, 2002 - Elsevier
Objectives: The objective of the study is to evaluate the agreement of local and review urinary
cytology in patients with newly diagnosed bladder cancer and in those being followed for …

The role of BTA stat Test in follow-up of patients with bladder cancer: results from FinnBladder studies

MP Raitanen, FinnBladder Group - World journal of urology, 2008 - Springer
Objectives To summarize the results of the FinnBladder studies of the BTA stat Test in follow-up
of bladder cancer and more importantly to provide guidelines for daily clinical practise. …

Perioperative single dose instillation of epirubicin or interferon-α after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: a …

P Rajala, E Kaasinen, M Raitanen… - The Journal of …, 2002 - auajournals.org
Purpose : We evaluated the long-term efficacy of a single dose of interferon or epirubicin
administered immediately after transurethral resection compared with transurethral resection …

Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (Stage pTa/T1) bladder cancer: a prospective comparative study

T Liukkonen, P Rajala, M Raitanen, E Rintala… - European …, 1999 - karger.com
Objective: A prospective randomized study was undertaken to determine whether cell
proliferation indices (M/V index, MIB1), papillary status, the expression of p53 and epidermal …

Complement factor H as a marker for detection of bladder cancer

…, PF Zipfel, RJ Kinders, M Raitanen… - Clinical …, 2005 - academic.oup.com
Background: The BTA TRAK™ and BTA stat™ tests for bladder cancer use monoclonal
antibodies (mAbs) X13.2 and X52.1 to detect factor H (FH)-related material in urine. The exact …

Charge-dependent targeting: results in six tumor cell lines

…, Z Liu, T Tammela, M Raitanen… - Anticancer …, 2004 - ar.iiarjournals.org
Background: Many previous studies show that cell surface sialylation of malignant cells is
enhanced compared to normal tissue. The carboxyl group of the sialic acid yields a negative …

Human complement factor H related protein test for monitoring bladder cancer

MP RAITANEN, T MARTTILA, M NURMI… - The Journal of …, 2001 - auajournals.org
Purpose : The BTA stat ‡ ‡ Bion Diagnostic Sciences, Inc., Redmond, Washington. test is a
rapid, noninvasive, qualitative urine test that detects bladder tumor associated antigen (…

Intravesical bacillus Calmette-Guérin versus combination of Epirubicin and interferon-α2a in reducing recurrence of non–muscle-invasive bladder carcinoma …

…, P Hellström, S Aaltomaa, M Leskinen, M Raitanen… - European urology, 2016 - Elsevier
Background Patients with non–muscle-invasive bladder cancer (NMIBC) belonging to the
intermediate-risk group should be treated with intravesical instillations to prevent recurrence …

Transurethral resection with perioperative instillation of interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer: a prospective …

P Rajala, T Liukkonen, M Raitanen, E Rintala… - The Journal of …, 1999 - auajournals.org
Purpose : We evaluated the efficacy of single dose of interferon or epirubicin administered
immediately after transurethral resection compared with transurethral resection only on the …

Analysis of false-positive BTA STAT test results in patients followed up for bladder cancer

MP Raitanen, E Kaasinen, O Lukkarinen, R Kauppinen… - Urology, 2001 - Elsevier
Objectives. To evaluate the role of a positive BTA stat Test result in patients with negative
cystoscopic findings. Methods. Five hundred one consecutive patients in follow-up for bladder …